Key Points
- WIRED examined nicotine analogs as a new issue in U.S. vape regulation.
- 6-methyl-nicotine has become one of the compounds drawing regulatory attention.
- Research suggests some nicotine analogs may have higher potency, but human data remains limited.
- Several U.S. states have expanded tobacco definitions to cover nicotine-like compounds.
- Federal policymakers are considering broader nicotine definitions.
2Firsts
July 27, 2026
U.S. technology and investigative publication WIRED recently examined how nicotine analogs are becoming a new challenge for the country’s vape regulatory system. The article argues that as regulators tighten oversight of traditional and synthetic nicotine products, new chemical compounds are emerging as another factor complicating enforcement.
WIRED said the U.S. vape market has long involved a tension between regulatory definitions and product innovation. After Congress expanded federal oversight of nicotine products in 2022 to include synthetic nicotine, some manufacturers began exploring other compounds designed to mimic nicotine effects.
The article’s assessments are based on reporting, researcher interviews and expert commentary, and do not establish that all companies using such compounds have violated regulations.
Nicotine Analogs Become New Focus of Vape Regulation
According to WIRED, some vape products have increasingly used nicotine analogs, compounds that resemble nicotine in structure or effects but may not fully fall within existing federal tobacco definitions.
One compound receiving attention is 6-methyl-nicotine.
The article said U.S. regulatory frameworks have historically focused on the legal definition of nicotine, creating potential gaps for emerging compounds.
Robert Jackler, an emeritus professor at Stanford University, said regulators are often forced to respond to rapidly changing product strategies as companies seek new ways to navigate rules.
However, research into the long-term human effects of nicotine analogs remains limited.
Studies Raise Questions Over 6-Methyl-Nicotine Potency
WIRED cited research suggesting that animal studies have found 6-methyl-nicotine may have greater potency and dependence potential than traditional nicotine.
Researchers have also emphasized that available evidence remains insufficient to determine long-term human health effects.
The article also referenced a 2024 study that found some nicotine analog vape products contained additional unlabeled ingredients, including artificial sweeteners and cooling agents, raising questions about inhalation risks.
Jackler said discrepancies between product labels and actual ingredients could create challenges for regulators and consumers.
Tobacco Companies Researched Similar Compounds Decades Ago
WIRED noted that nicotine analogs are not a new scientific concept.
Since the 1970s, major tobacco companies have researched nicotine-like compounds as potential alternatives to nicotine.
A 2005 review of previously confidential tobacco industry documents found that companies had explored such compounds partly because they believed they could help address future regulatory challenges.
However, these compounds were never widely commercialized in mainstream tobacco products.
They have now reappeared in some vape products, renewing regulatory attention.
U.S. Regulators Consider Expanding Nicotine Definition
Federal regulation of nicotine analogs remains incomplete in the United States.
WIRED reported that California, Nebraska, Indiana and Tennessee have expanded tobacco product definitions to include certain nicotine-like compounds.
The article also noted that the U.S. government’s proposed Fiscal Year 2027 budget includes a legislative proposal to expand the definition of nicotine, allowing nicotine analogs to be regulated by the FDA.
The proposal states that such compounds could be “more potent, addictive, and cytotoxic than nicotine.”
If enacted, the change could create new compliance requirements for vape and nicotine product companies.
Vape Regulation Moves Toward Chemical Definitions
The nicotine analog debate shows that U.S. vape regulation is moving beyond products and into chemical composition and legal definitions.
Historically, regulators focused on:
- product authorization;
- tobacco compliance;
- youth access concerns.
Future oversight may increasingly examine:
- specific chemical compounds;
- the scope of nicotine definitions;
- potential risks of emerging substances.
For vape companies, future competition will depend not only on product innovation but also on regulatory adaptability, ingredient transparency and compliance systems.
Follow 2Firsts for the latest updates on global tobacco and nicotine regulation, industry developments and market trends.
Cover Image source: WIRED
